News & Events
Valhalla, N.Y. – September 12, 2018 – New York Medical College (NYMC) announced that Affina Biotechnologies is the latest client to join BioInc@NYMC, NYMC’s biotechnology incubator — a New York State-designated Innovation Hot Spot. Affina Biotechnologies is a drug discovery start up that also offers services in protein biochemistry and assay development. There are currently nine start-ups occupying BioInc@NYMC, the mid-Hudson Valley’s only fully-equipped incubator on a health sciences college campus.
In 2014, Samant Virk was more than a decade into a career in private practice as a neurologist in Poughkeepsie, but he couldn’t shake the feeling that something
HARRISON, N.Y., June 26, 2018 (GLOBE NEWSWIRE) -- Sapience Therapeutics, Inc., a biotechnology company focused on developing peptide therapeutics to address difficult to treat oncology indications, announced today that it was selected by Johnson & Johnson Innovation, JLABS (JLABS) as a winner of the JLABS @ NYC QuickFire challenge. Sapience was awarded one year of residency at the JLABS @ NYC, which includes laboratory space and access to Johnson & Johnson Innovation’s network of experts.
“This event is a part of our mission to foster entrepreneurship and economic growth in New York State,” said Deborah Novick, director of BioInc@NYMC.
We are seeing tremendous medical innovation come out of Israel, but many of these companies lack the knowledge and experience to successfully expand in the U.S.
Inspired by the NYMC’s innovation around biotechnology and state-of-the-art medical equipment, President Morales plans to take key learning points back to people of Guatemala.
Crave Crush helps individuals lead healthier lives by eating less sugar. The main ingredient in its patented lozenge is gymnema, a natural leaf extract that supports healthy dietary habits.
BioInc@NYMC has established itself as the premier biomedical incubator in the region and I am eager to join and help support its mission and the success of its members
SHY Therapeutics and MediSprout Join NYMC’S Innovative Biotech Incubator
Sapience Therapeutics, Inc. Developing Therapeutic Agent to Address High Mortality Cancers
NYMC Biotechnology Incubator Receives More Than One Million Dollars in State Funding To Support Innovation Hot Spot
BioInc@NYMC has seen phenomenal growth and success in its short three-year history
Four LLC to Become Fourth Member of the College’s Innovative Biotech Incubator
BioInc@NYMC is the only incubator of its kind in the region that is located on a medical school campus
BioInc@NYMC funded to help improve New York’s competitiveness in growing new technology based companies
BioInc@NYMC is a vibrant, intellectually supportive platform for innovation and development that encourages collaboration and synergistic relationships among entrepreneurs.